Elective percutaneous intervention for intracranial atherosclerotic stenoses by interventional cardiologists

Ramy A Badawi1, Christopher J White, Tyrone J Collins

  • 1Department of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA. rbadawi@msn.com

Insights

Catheter-based therapy (CBT) for symptomatic intracranial atherosclerotic disease offers high success and good outcomes. This treatment is a safe option for high-risk patients who have not responded to medical therapy.

Area of Science:

  • Cardiology
  • Neurology
  • Interventional Radiology

Background:

  • Symptomatic atherosclerotic intracranial disease carries a high risk of recurrence despite optimal medical therapy.
  • Catheter-based therapy (CBT) presents an alternative for patients unresponsive to medical management.
  • This study evaluates CBT outcomes in patients with intracranial arterial disease.

Purpose of the Study:

  • To assess the safety and efficacy of catheter-based therapy (CBT) for symptomatic intracranial arterial disease.
  • To examine the procedural success and clinical outcomes of CBT in a high-risk patient cohort.
  • To compare CBT outcomes against the expected recurrence rates of medical therapy.

Main Methods:

  • Retrospective analysis of 89 consecutive patients with 99 significant (≥70% diameter) intracranial arterial stenoses.
  • CBT performed by experienced interventional cardiologists with neurovascular team support.
  • Primary endpoint: stroke and vascular death; secondary endpoints included procedural success and mortality.

Main Results:

  • High procedural success rate of 97% (96/99 lesions).
  • Significant reduction in diameter stenosis from 91% to 19% (P < 0.001).
  • 1-year stroke and vascular death rate of 5.7%; 2-year rate of 13.5%. In-hospital stroke/death rate was 3%.

Conclusions:

  • CBT is safe and effective for symptomatic intracranial arterial stenosis in patients who failed medical therapy.
  • High procedural success and excellent 1-year clinical outcomes were observed.
  • CBT is an attractive option for high-risk patients, offering an alternative to high recurrence rates with medical therapy.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...